Persantine IV

(Generic versions may still be available.)

DRUG DESCRIPTION

Persantine® (dipyridamole USP) for intravenous injection is a coronary vasodilator described as 2,6-Bis(diethanolamino)-4,8-dipiperidinopy-rimido [5,4-d]-pyrimidine.

Dipyridamole in solution is an odorless, pale yellow liquid which can be diluted in normal saline and dextrose and water for intravenous administration.

IV Persantine® as a sterile solution for intravenous administration contains:

Active Ingredient VIAL10 mL: dipyridamole USP 50 mg.

Inactive Ingredients VIAL10 mL: polyethylene glycol 600 500 mg, tartaric acid 20 mg. pH is adjusted to 2.7 ±0.5 with hydrochloric acid.

What are the precautions when taking persantine (Persantine IV)?

Consult your...

Read All Potential Precautions of Persantine IV »


Persantine IV Consumer (continued)

SIDE EFFECTS: Consult your pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

PRECAUTIONS: Consult your pharmacist.



Related Drugs Index: